Corporate governance and firm strategy in the pharmaceutical industry:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Berlin
WZB
1997
|
| Schriftenreihe: | Discussion papers / Wissenschaftszentrum Berlin für Sozialforschung, Forschungsschwerpunkt Marktprozeß und Unternehmensentwicklung
|
| Schlagworte: | |
| Beschreibung: | 27 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV024428886 | ||
| 003 | DE-604 | ||
| 005 | 20231123 | ||
| 007 | t | ||
| 008 | 980127s1997 d||| t||| 00||| eng d | ||
| 035 | |a (OCoLC)75879242 | ||
| 035 | |a (DE-599)BVBBV024428886 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-83 |a DE-188 | ||
| 088 | |a FS IV 97 20 | ||
| 100 | 1 | |a Casper, Steven |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Corporate governance and firm strategy in the pharmaceutical industry |c Steven Casper ; Catherine Matraves |
| 264 | 1 | |a Berlin |b WZB |c 1997 | |
| 300 | |a 27 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Discussion papers / Wissenschaftszentrum Berlin für Sozialforschung, Forschungsschwerpunkt Marktprozeß und Unternehmensentwicklung | |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Corporate Governance |0 (DE-588)4419850-4 |2 gnd |9 rswk-swf |
| 651 | 7 | |a Großbritannien |0 (DE-588)4022153-2 |2 gnd |9 rswk-swf | |
| 651 | 7 | |a Deutschland |0 (DE-588)4011882-4 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a Deutschland |0 (DE-588)4011882-4 |D g |
| 689 | 0 | 1 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 2 | |a Corporate Governance |0 (DE-588)4419850-4 |D s |
| 689 | 0 | 3 | |a Großbritannien |0 (DE-588)4022153-2 |D g |
| 689 | 0 | |5 DE-188 | |
| 700 | 1 | |a Matraves, Catherine |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-018406221 | ||
Datensatz im Suchindex
| _version_ | 1804140402331090944 |
|---|---|
| any_adam_object | |
| author | Casper, Steven |
| author_facet | Casper, Steven |
| author_role | aut |
| author_sort | Casper, Steven |
| author_variant | s c sc |
| building | Verbundindex |
| bvnumber | BV024428886 |
| ctrlnum | (OCoLC)75879242 (DE-599)BVBBV024428886 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01458nam a2200385 c 4500</leader><controlfield tag="001">BV024428886</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20231123 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">980127s1997 d||| t||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)75879242</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV024428886</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-83</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="088" ind1=" " ind2=" "><subfield code="a">FS IV 97 20</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Casper, Steven</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Corporate governance and firm strategy in the pharmaceutical industry</subfield><subfield code="c">Steven Casper ; Catherine Matraves</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin</subfield><subfield code="b">WZB</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">27 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Discussion papers / Wissenschaftszentrum Berlin für Sozialforschung, Forschungsschwerpunkt Marktprozeß und Unternehmensentwicklung</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Corporate Governance</subfield><subfield code="0">(DE-588)4419850-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Großbritannien</subfield><subfield code="0">(DE-588)4022153-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Deutschland</subfield><subfield code="0">(DE-588)4011882-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Deutschland</subfield><subfield code="0">(DE-588)4011882-4</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Corporate Governance</subfield><subfield code="0">(DE-588)4419850-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Großbritannien</subfield><subfield code="0">(DE-588)4022153-2</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-188</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Matraves, Catherine</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-018406221</subfield></datafield></record></collection> |
| geographic | Großbritannien (DE-588)4022153-2 gnd Deutschland (DE-588)4011882-4 gnd |
| geographic_facet | Großbritannien Deutschland |
| id | DE-604.BV024428886 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T21:59:24Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-018406221 |
| oclc_num | 75879242 |
| open_access_boolean | |
| owner | DE-83 DE-188 |
| owner_facet | DE-83 DE-188 |
| physical | 27 S. graph. Darst. |
| publishDate | 1997 |
| publishDateSearch | 1997 |
| publishDateSort | 1997 |
| publisher | WZB |
| record_format | marc |
| series2 | Discussion papers / Wissenschaftszentrum Berlin für Sozialforschung, Forschungsschwerpunkt Marktprozeß und Unternehmensentwicklung |
| spelling | Casper, Steven Verfasser aut Corporate governance and firm strategy in the pharmaceutical industry Steven Casper ; Catherine Matraves Berlin WZB 1997 27 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Discussion papers / Wissenschaftszentrum Berlin für Sozialforschung, Forschungsschwerpunkt Marktprozeß und Unternehmensentwicklung Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Corporate Governance (DE-588)4419850-4 gnd rswk-swf Großbritannien (DE-588)4022153-2 gnd rswk-swf Deutschland (DE-588)4011882-4 gnd rswk-swf Deutschland (DE-588)4011882-4 g Pharmazeutische Industrie (DE-588)4045696-1 s Corporate Governance (DE-588)4419850-4 s Großbritannien (DE-588)4022153-2 g DE-188 Matraves, Catherine Sonstige oth |
| spellingShingle | Casper, Steven Corporate governance and firm strategy in the pharmaceutical industry Pharmazeutische Industrie (DE-588)4045696-1 gnd Corporate Governance (DE-588)4419850-4 gnd |
| subject_GND | (DE-588)4045696-1 (DE-588)4419850-4 (DE-588)4022153-2 (DE-588)4011882-4 |
| title | Corporate governance and firm strategy in the pharmaceutical industry |
| title_auth | Corporate governance and firm strategy in the pharmaceutical industry |
| title_exact_search | Corporate governance and firm strategy in the pharmaceutical industry |
| title_full | Corporate governance and firm strategy in the pharmaceutical industry Steven Casper ; Catherine Matraves |
| title_fullStr | Corporate governance and firm strategy in the pharmaceutical industry Steven Casper ; Catherine Matraves |
| title_full_unstemmed | Corporate governance and firm strategy in the pharmaceutical industry Steven Casper ; Catherine Matraves |
| title_short | Corporate governance and firm strategy in the pharmaceutical industry |
| title_sort | corporate governance and firm strategy in the pharmaceutical industry |
| topic | Pharmazeutische Industrie (DE-588)4045696-1 gnd Corporate Governance (DE-588)4419850-4 gnd |
| topic_facet | Pharmazeutische Industrie Corporate Governance Großbritannien Deutschland |
| work_keys_str_mv | AT caspersteven corporategovernanceandfirmstrategyinthepharmaceuticalindustry AT matravescatherine corporategovernanceandfirmstrategyinthepharmaceuticalindustry |